Rosuvastatin 20mg placebo

DRUG2 trials

Sponsors

LG Life Sciences, Alvogen Korea

Conditions

CholesterolemiaHyperlipidemiaHypertensionHypertension,

Phase 3

Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia

CompletedNCT01918332

LG Life SciencesHyperlipidemia, Hypertension,

Start: 2012-04-30End: 2013-03-31Updated: 2014-12-15

Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

CompletedNCT02770261

Alvogen KoreaCholesterolemia, Hypertension

Start: 2015-12-31End: 2016-10-31Updated: 2016-12-26

Related Papers

Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study.

2019-07-1210 citations